Cargando…
Association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: A cross-sectional analysis
Lignan polyphenols derived from plants are metabolized by bacteria in the gut to mammalian lignans, such as enterolactone (ENL) and enterodiol (END). Mammalian lignan intake has been reported to be associated with obesity and low blood glucose levels. However, the factors that are responsible for in...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695372/ https://www.ncbi.nlm.nih.gov/pubmed/38048315 http://dx.doi.org/10.1371/journal.pone.0295185 |
_version_ | 1785153552092495872 |
---|---|
author | Fujitani, Tomoko Harada Sassa, Mariko Lyu, Zhaoqing Fujii, Yukiko Harada, Kouji H. |
author_facet | Fujitani, Tomoko Harada Sassa, Mariko Lyu, Zhaoqing Fujii, Yukiko Harada, Kouji H. |
author_sort | Fujitani, Tomoko |
collection | PubMed |
description | Lignan polyphenols derived from plants are metabolized by bacteria in the gut to mammalian lignans, such as enterolactone (ENL) and enterodiol (END). Mammalian lignan intake has been reported to be associated with obesity and low blood glucose levels. However, the factors that are responsible for individual differences in the metabolic capacity for ENL and END are not well understood. In the present study, the effects of enterotypes of isoflavone metabolism, equol producers (EQP) and O-desmethylangolensin producers (O-DMAP), on lignan metabolism were examined. EQP was defined by urinary daidzein (DAI) and equol concentrations as log(equol/DAI) ≥ –1.42. O-DMAP was defined by urinary DAI and O-DMA concentrations as O-DMA/DAI > 0.018. Isoflavone and lignan concentrations in urine samples from 440 Japanese women were measured by gas chromatography-mass spectrometry. Metabolic enterotypes were determined from the urinary equol and O-DMA concentrations. Urinary END and ENL concentrations were compared in four groups, combinations of EQP (+/–) and O-DMAP (+/–). The urinary lignan concentration was significantly higher in the O-DMAP/EQP group (ENL: P<0.001, END: P<0.001), and this association remained significant after adjusting for several background variables (END: β = 0.138, P = 0.00607 for EQP and β = 0.147, P = 0.00328 for O-DMAP; ENL: β = 0.312, P<0.001 for EQP and β = 0.210, P<0.001 for O-DMAP). The ENL/END ratio was also highest in the O-DMAP/EQP group, indicating that equol and O-DMA metabolizing gut bacteria may be involved in lignan metabolism. In conclusion, urinary lignan concentrations were significantly higher in groups containing either EQP or O-DMAP than in the non-EQP/non-O-DMAP group. The variables and participants in this study were limited, which the possibility of confounding by other variables cannot be ruled out. However, there are no established determinants of lignan metabolism to date. Further research is needed to determine what factors should be considered, and to examine in different settings to confirm the external validity. |
format | Online Article Text |
id | pubmed-10695372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-106953722023-12-05 Association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: A cross-sectional analysis Fujitani, Tomoko Harada Sassa, Mariko Lyu, Zhaoqing Fujii, Yukiko Harada, Kouji H. PLoS One Research Article Lignan polyphenols derived from plants are metabolized by bacteria in the gut to mammalian lignans, such as enterolactone (ENL) and enterodiol (END). Mammalian lignan intake has been reported to be associated with obesity and low blood glucose levels. However, the factors that are responsible for individual differences in the metabolic capacity for ENL and END are not well understood. In the present study, the effects of enterotypes of isoflavone metabolism, equol producers (EQP) and O-desmethylangolensin producers (O-DMAP), on lignan metabolism were examined. EQP was defined by urinary daidzein (DAI) and equol concentrations as log(equol/DAI) ≥ –1.42. O-DMAP was defined by urinary DAI and O-DMA concentrations as O-DMA/DAI > 0.018. Isoflavone and lignan concentrations in urine samples from 440 Japanese women were measured by gas chromatography-mass spectrometry. Metabolic enterotypes were determined from the urinary equol and O-DMA concentrations. Urinary END and ENL concentrations were compared in four groups, combinations of EQP (+/–) and O-DMAP (+/–). The urinary lignan concentration was significantly higher in the O-DMAP/EQP group (ENL: P<0.001, END: P<0.001), and this association remained significant after adjusting for several background variables (END: β = 0.138, P = 0.00607 for EQP and β = 0.147, P = 0.00328 for O-DMAP; ENL: β = 0.312, P<0.001 for EQP and β = 0.210, P<0.001 for O-DMAP). The ENL/END ratio was also highest in the O-DMAP/EQP group, indicating that equol and O-DMA metabolizing gut bacteria may be involved in lignan metabolism. In conclusion, urinary lignan concentrations were significantly higher in groups containing either EQP or O-DMAP than in the non-EQP/non-O-DMAP group. The variables and participants in this study were limited, which the possibility of confounding by other variables cannot be ruled out. However, there are no established determinants of lignan metabolism to date. Further research is needed to determine what factors should be considered, and to examine in different settings to confirm the external validity. Public Library of Science 2023-12-04 /pmc/articles/PMC10695372/ /pubmed/38048315 http://dx.doi.org/10.1371/journal.pone.0295185 Text en © 2023 Fujitani et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Fujitani, Tomoko Harada Sassa, Mariko Lyu, Zhaoqing Fujii, Yukiko Harada, Kouji H. Association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: A cross-sectional analysis |
title | Association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: A cross-sectional analysis |
title_full | Association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: A cross-sectional analysis |
title_fullStr | Association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: A cross-sectional analysis |
title_full_unstemmed | Association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: A cross-sectional analysis |
title_short | Association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: A cross-sectional analysis |
title_sort | association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: a cross-sectional analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695372/ https://www.ncbi.nlm.nih.gov/pubmed/38048315 http://dx.doi.org/10.1371/journal.pone.0295185 |
work_keys_str_mv | AT fujitanitomoko associationbetweenlignanpolyphenolbioavailabilityandenterotypesofisoflavonemetabolismacrosssectionalanalysis AT haradasassamariko associationbetweenlignanpolyphenolbioavailabilityandenterotypesofisoflavonemetabolismacrosssectionalanalysis AT lyuzhaoqing associationbetweenlignanpolyphenolbioavailabilityandenterotypesofisoflavonemetabolismacrosssectionalanalysis AT fujiiyukiko associationbetweenlignanpolyphenolbioavailabilityandenterotypesofisoflavonemetabolismacrosssectionalanalysis AT haradakoujih associationbetweenlignanpolyphenolbioavailabilityandenterotypesofisoflavonemetabolismacrosssectionalanalysis |